Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epidermal growth factor receptor (EGFR) signaling and covalent EGFR inhibition in lung cancer.

× No keyword cloud information.

17 in total

1. Clinicopathological features of Chinese lung cancer patients with epidermal growth factor receptor mutation.

Authors: Hui Ning; Ming Liu; Lina Wang; Yang Yang; Nan Song; Xiaoxiong Xu; Jin Ju; Gening Jiang
Journal: J Thorac Dis Date: 2017-03 Impact factor: 2.895

2. Biological properties of ligand-dependent activation of the MET receptor kinase in acute myeloid leukemia.

Authors: S F McGee; S M Kornblau; Y Qiu; A T Look; N Zhang; S-Y Yoo; K R Coombes; A Kentsis
Journal: Leukemia Date: 2014-12-26 Impact factor: 11.528

3. Involvement of nuclear protein C23 in activation of EGFR signaling in cervical cancer.

Authors: Junyuan Yan; Yanling Zhang; Cuili Ren; Wenshuang Shi; Lijun Chen
Journal: Tumour Biol Date: 2015-08-10

4. Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance.

Authors: Phillip A Schwartz; Petr Kuzmic; James Solowiej; Simon Bergqvist; Ben Bolanos; Chau Almaden; Asako Nagata; Kevin Ryan; Junli Feng; Deepak Dalvie; John C Kath; Meirong Xu; Revati Wani; Brion William Murray
Journal: Proc Natl Acad Sci U S A Date: 2013-12-17 Impact factor: 11.205

Review 5. The war on cancer: are we winning?

Authors: M J Duffy
Journal: Tumour Biol Date: 2013-04-09

Review 6. Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies.

Authors: S Carrera; A Buque; E Azkona; U Aresti; B Calvo; A Sancho; M Arruti; M Nuño; I Rubio; A R de Lobera; C Lopez; G L Vivanco
Journal: Clin Transl Oncol Date: 2013-12-04 Impact factor: 3.405

Review 7. Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer: EGFR and beyond.

Authors: Christopher Delaney; Samuel Frank; R Stephanie Huang
Journal: Chin J Cancer Date: 2015-04-08

8. Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells.

Authors: F Caiazza; P M McGowan; M Mullooly; A Murray; N Synnott; N O'Donovan; L Flanagan; C J Tape; G Murphy; J Crown; M J Duffy
Journal: Br J Cancer Date: 2015-05-26 Impact factor: 7.640

9. Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma.

Authors: Janet Wangari-Talbot; Elizabeth Hopper-Borge
Journal: J Can Res Updates Date: 2013-10-31

10. Cytohesins/ARNO: the function in colorectal cancer cells.

Authors: Tao Pan; Junfeng Sun; Jiyi Hu; Yiwang Hu; Jun Zhou; Zhigang Chen; Dong Xu; Wenhong Xu; Shu Zheng; Suzhan Zhang
Journal: PLoS One Date: 2014-03-11 Impact factor: 3.240